Alaunos Therapeutics, Inc. - TCRT

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q1 2026 · Q4 2025
Value (USD)
Total reported value ($000)
$452K
QoQ value delta ($000)
+$109K (+31.78%)
Implied price effect (QoQ)
-8.48%
Shares
Total shares
156,299
QoQ shares delta
+47,749 (+43.99%)
Total shares held by funds (by quarter)

Market chart (TCRT)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q1 2026)

Top 25 only Full list
Partial Q1 2026 data: 29 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 97 30,061 0.0%
GEODE CAPITAL MANAGEMENT, LLC 64 22,560 0.0%
BlackRock, Inc. 61 21,353 0.0%
VANGUARD FIDUCIARY TRUST CO 44 15,497 0.0%
VANGUARD CAPITAL MANAGEMENT LLC 40 14,063 0.0%
HRT FINANCIAL LP 38 13,327 0.0%
TWO SIGMA INVESTMENTS, LP 31 10,839 0.0%
CITADEL ADVISORS LLC 30 10,519 0.0%
XTX Topco Ltd 29 10,174 0.0%
UBS Group AG 6 2,274 0.0%
OSAIC HOLDINGS, INC. 5 1,779 0.0%
Tower Research Capital LLC (TRC) 4 1,583 0.0%
MORGAN STANLEY 1 653 0.0%
ROYAL BANK OF CANADA 1 185 0.0%
Vanguard Global Advisers, LLC 1 501 0.0%
WELLS FARGO & COMPANY/MN 0 190 0.0%
NBC SECURITIES, INC. 0 20 0.0%
CITIGROUP INC 0 1 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 6 0.0%
CIBC Private Wealth Group LLC 0 300 0.0%
AdvisorNet Financial, Inc 0 19 0.0%
SIGNATUREFD, LLC 0 23 0.0%
CWM, LLC 0 8 0.0%
Sunbelt Securities, Inc. 0 10 0.0%
Inspire Investing, LLC 0 9 0.0%